BioAtla Inc (NASDAQ:BCAB) has a beta value of 1.01 and has seen 1.02 million shares traded in the last trading session. The company, currently valued at $182.78M, closed the last trade at $3.80 per share which meant it lost -$0.12 on the day or -3.06% during that session. The BCAB stock price is -7.11% off its 52-week high price of $4.07 and 67.37% above the 52-week low of $1.24. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.11 million shares traded. The 3-month trading volume is 506.29K shares.
BioAtla Inc (NASDAQ:BCAB) trade information
Sporting -3.06% in the red in last session, the stock has traded in the green over the last five days, when the BCAB stock price touched $3.80 or saw a rise of 5.47%. Year-to-date, BioAtla Inc shares have moved 54.47%, while the 5-day performance has seen it change 10.47%. Over the past 30 days, the shares of BioAtla Inc (NASDAQ:BCAB) have changed 33.80%. Short interest in the company has seen 5.13 million shares shorted with days to cover at 14.48.
BioAtla Inc (BCAB) estimates and forecasts
Figures show that BioAtla Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 136.02% over the past 6 months, with this year growth rate of 25.19%, compared to 13.50% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are -25.40% and 6.90% for the next quarter.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -25.30% over the past 5 years.
BCAB Dividends
BioAtla Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
BioAtla Inc (NASDAQ:BCAB)’s Major holders
Insiders own 9.69% of the company shares, while shares held by institutions stand at 64.79% with a share float percentage of 71.74%. Investors are also buoyed by the number of investors in a company, with BioAtla Inc having a total of 114 institutions that hold shares in the company. The top two institutional holders are Soleus Capital Management, L.P. with over 4.32 million shares worth more than $12.96 million. As of Jun 29, 2023, Soleus Capital Management, L.P. held 9.04% of shares outstanding.
The other major institutional holder is Tang Capital Management, LLC, with the holding of over 3.67 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $11.02 million and represent 7.69% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Wasatch Ultra Growth Fund. As of Jun 29, 2023, the former fund manager holds about 2.73% shares in the company for having 1.3 million shares of worth $3.91 million while later fund manager owns 1.1 million shares of worth $3.31 million as of Jun 29, 2023, which makes it owner of about 2.31% of company’s outstanding stock.
